4.5 Article

Hybrid Method Inference for the Construction of Cooperative Regulatory Network in Human

Journal

IEEE TRANSACTIONS ON NANOBIOSCIENCE
Volume 13, Issue 2, Pages 97-103

Publisher

IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
DOI: 10.1109/TNB.2014.2316920

Keywords

Cancer; ensemble methods; gene regulatory network (GRN); linear regression

Funding

  1. INCa (French National Institute of Cancer) through the INCa project [PL-2010-196]

Ask authors/readers for more resources

Reconstruction of large scale gene regulatory networks (GRNs in the following) is an important step for understanding the complex regulatory mechanisms within the cell. Many modeling approaches have been introduced to find the causal relationship between genes using expression data. However, they have been suffering from high dimensionality-large number of genes but a small number of samples, overfitting, heavy computation time and low interpretability. We have previously proposed an original Data Mining algorithm LICORN, that infers cooperative regulation network from expression datasets. In this work, we present an extension of LICORN to a hybrid inference method H-LICORN that uses search in both discrete and real valued spaces. LICORN's algorithm, using the discrete space to find cooperative regulation relationships fitting the target gene expression, has been shown to be powerful in identifying cooperative regulation relationships that are out of the scope of most GRN inference methods. Still, as many of related GRN inference techniques, LICORN suffers from a large number of false positives. We propose here an extension of LICORN with a numerical selection step, expressed as a linear regression problem, that effectively complements the discrete search of LICORN. We evaluate a bootstrapped version of H-LICORN on the in silico DREAM5 dataset and show that H-LICORN has significantly higher performance than LICORN, and is competitive or outperforms state of the art GRN inference algorithms, especially when operating on small data sets. We also applied H-LICORN on a real dataset of human bladder cancer and show that it performs better than other methods in finding candidate regulatory interactions. In particular, solely based on gene expression data, H-LICORN is able to identify experimentally validated regulator cooperative relationships involved in cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Computer Science, Information Systems

Evolutionary mining of skyline clusters of attributed graph data

Wajdi Dhifli, Nour El Islem Karabadji, Mohamed Elati

INFORMATION SCIENCES (2020)

Article Oncology

hENT1 Testing in Pancreatic Ductal Adenocarcinoma: Are We Ready? A Multimodal Evaluation of hENT1 Status

Jerome Raffenne, Remy Nicolle, Francesco Puleo, Delphine Le Corre, Camille Boyez, Raphael Marechal, Jean Francois Emile, Peter Demetter, Armelle Bardier, Pierre Laurent-Puig, Louis de Mestier, Valerie Paradis, Anne Couvelard, Jean Luc VanLathem, John R. MacKey, Jean-Baptiste Bachet, Magali Svrcek, Jerome Cros

CANCERS (2019)

Article Biochemistry & Molecular Biology

Basal-like and classical cells coexist in pancreatic cancer revealed by single-cell analysis on biopsy-derived pancreatic cancer organoids from the classical subtype

Natalia Juiz, Abdessamad Elkaoutari, Martin Bigonnet, Odile Gayet, Julie Roques, Remy Nicolle, Juan Iovanna, Nelson Dusetti

FASEB JOURNAL (2020)

Article Medicine, General & Internal

Establishment of a pancreatic adenocarcinoma molecular gradient (PAMG) that predicts the clinical outcome of pancreatic cancer

Remy Nicolle, Yuna Blum, Pauline Duconseil, Charles Vanbrugghe, Nicolas Brandone, Flora Poizat, Julie Roques, Martin Bigonnet, Odile Gayet, Marion Rubis, Nabila Elarouci, Lucile Armenoult, Mira Ayadi, Aurelien de Reynies, Marc Giovannini, Philippe Grandval, Stephane Garcia, Cindy Canivet, Jerome Cros, Barbara Bournet, Louis Buscail, Vincent Moutardier, Marine Gilabert, Juan Iovanna, Nelson Dusetti

EBIOMEDICINE (2020)

Review Oncology

Cancer-Associated Fibroblasts: Accomplices in the Tumor Immune Evasion

Marc Hilmi, Remy Nicolle, Corinne Bousquet, Cindy Neuzillet

CANCERS (2020)

Article Oncology

Pancreatic Ductal Adenocarcinoma Arising in Young and Old Patients Displays Similar Molecular Features

Jerome Raffenne, Fernando A. Martin, Remy Nicolle, Marina Konta, Yuna Blum, Jerome Torrisani, Francesco Puleo, Jean Baptiste Bachet, Magali Svrcek, Armel Bardier-Dupas, Jean Francois Emile, Peter Demetter, Miroslav Radman, Jean Luc Van Laethem, Pascal Hammel, Vinciane Rebours, Valerie Paradis, Anne Couvelard, Jerome Cros

Summary: Pancreatic ductal adenocarcinoma (PDAC) is typically diagnosed in the 7th decade, but around 10% of patients are diagnosed before the age of 55. Molecular features of early-onset tumors (<= 55 y.o.) were found to be similar to late-onset tumors (>= 70 y.o.), indicating that younger patients can serve as a good molecular surrogate model for the general older population with PDAC. The study also highlighted the impact of ageing on DNA methylation and proteome integrity, as well as the association of oxidative stress responses with PDAC.

CANCERS (2021)

Review Oncology

Pancreatic Cancer Meets Human Microbiota: Close Encounters of the Third Kind

Tatjana Arsenijevic, Remy Nicolle, Christelle Bouchart, Nicky D'Haene, Pieter Demetter, Francesco Puleo, Jean-Luc Van Laethem

Summary: Microbiota on oral, gut, and intratumoral regions have significant impacts on the development, progression, and chemoresistance of pancreatic ductal adenocarcinoma, potentially serving as diagnostic, prognostic, and predictive biomarkers for this aggressive cancer.

CANCERS (2021)

Article Oncology

Exploring the Complementarity of Pancreatic Ductal Adenocarcinoma Preclinical Models

Owen Hoare, Nicolas Fraunhoffer, Abdessamad Elkaoutari, Odile Gayet, Martin Bigonnet, Julie Roques, Remy Nicolle, Colin McGuckin, Nico Forraz, Emilie Sohier, Laurie Tonon, Pauline Wajda, Sandrine Boyault, Valery Attignon, Severine Tabone-Eglinger, Sandrine Barbier, Caroline Mignard, Olivier Duchamp, Juan Iovanna, Nelson J. Dusetti

Summary: The study compares three preclinical models directly derived from PDAC patients, showing their unique basal-like/classical transcriptomic phenotype significantly influences global chemosensitivity. Each model is imperfect but complementary, suggesting a more representative clinical approach could be achieved by combining them.

CANCERS (2021)

Article Health Care Sciences & Services

Inference of an Integrative, Executable Network for Rheumatoid Arthritis Combining Data-Driven Machine Learning Approaches and a State-of-the-Art Mechanistic Disease Map

Quentin Miagoux, Vidisha Singh, Dereck de Mezquita, Valerie Chaudru, Mohamed Elati, Elisabeth Petit-Teixeira, Anna Niarakis

Summary: Rheumatoid arthritis is a complex autoimmune disease with various genetic and environmental factors. By using systems biology approaches and machine learning, researchers aim to uncover mechanisms regulating key transcription factors and derive patient-specific models. Integrating multiple data types can help analyze disease heterogeneity and treatment response in a more comprehensive manner.

JOURNAL OF PERSONALIZED MEDICINE (2021)

Article Pathology

Immunophenotypic and molecular characterization of pancreatic neuroendocrine tumors producing serotonin

Thomas Depoilly, Raffaele Leroux, Dafne Andrade, Remy Nicolle, Marco Dioguardi Burgio, Ilaria Marinoni, Safi Dokmak, Philippe Ruszniewski, Olivia Hentic, Valerie Paradis, Louis De Mestier, Aurel Perren, Anne Couvelard, Jerome Cros

Summary: Serotonin producing pancreatic neuroendocrine tumors (SP-PanNET) are a distinct and specific subtype of pancreatic neuroendocrine tumors with atypical serotonin secretion and abundant dense stroma deposition. They have a unique genomic profile and activation of the TGF-beta pathway, leading to the characteristic fibrotic aspect. The cell of origin within the pancreas is still unclear.

MODERN PATHOLOGY (2022)

Article Oncology

Multi-omics data integration and modeling unravels new mechanisms for pancreatic cancer and improves prognostic prediction

Nicolas A. Fraunhoffer, Analia Meilerman Abuelafia, Martin Bigonnet, Odile Gayet, Julie Roques, Remy Nicolle, Gwen Lomberk, Raul Urrutia, Nelson Dusetti, Juan Iovanna

Summary: This study developed a Master Regulators (MR)-Gradient model based on transcriptomic profiles derived from both PDAC epithelial and microenvironment cells to reveal the transcriptional networks, epigenomic states, and metabolic pathways underlying PDAC heterogeneity. Integration of methylome and metabolome datasets, along with experimental measurements, showed a close association between PDAC prognosis, tumor epithelial cell phenotype, and immunological component. Metabolic analysis indicated a positive correlation between favorable PDAC phenotype and enzymes involved in complex lipid biosynthesis, while an unfavorable phenotype exhibited an OXPHOS independent metabolism centered on the Warburg effect and glutaminolysis. The study also identified key deregulated pathways in PDAC related to epigenetics.

NPJ PRECISION ONCOLOGY (2022)

Article Oncology

Periostin- and podoplanin-positive cancer-associated fibroblast subtypes cooperate to shape the inflamed tumor microenvironment in aggressive pancreatic adenocarcinoma

Cindy Neuzillet, Remy Nicolle, Jerome Raffenne, Annemilai Tijeras-Raballand, Alexia Brunel, Lucile Astorgues-Xerri, Sophie Vacher, Floriane Arbateraz, Marjorie Fanjul, Marc Hilmi, Remi Samain, Christophe Klein, Aurelie Perraud, Vinciane Rebours, Muriel Mathonnet, Ivan Bieche, Hemant Kocher, Jerome Cros, Corinne Bousquet

Summary: This study refined the subtypes of cancer-associated fibroblasts (CAFs) in pancreatic ductal adenocarcinoma (PDAC) using RNAseq and immunostaining, and found associations between different CAF subtypes and tumor characteristics as well as patient survival. Periostin-positive CAFs were linked to aggressive tumors, while podoplanin-positive CAFs were associated with immune-related phenotypes.

JOURNAL OF PATHOLOGY (2022)

Article Oncology

Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression

Matteo Ponzo, Anais Debesset, Melissande Cossutta, Mounira Chalabi-Dchar, Claire Houppe, Caroline Pilon, Alba Nicolas-Boluda, Sylvain Meunier, Fabio Raineri, Allan Thiolat, Remy Nicolle, Federica Maione, Serena Brundu, Carina Florina Cojocaru, Philippe Bouvet, Corinne Bousquet, Florence Gazeau, Christophe Tournigand, Jose Courty, Enrico Giraudo, Jose L. Cohen, Ilaria Cascone

Summary: This study explores the effects of a selective inhibitor of nucleolin (NCL) on the immune microenvironment of pancreatic ductal adenocarcinoma (PDAC), and highlights a new therapeutic strategy to restrain immunosuppressive cells, promote T-cell recruitment and activation, and re-program the tumor stroma of PDAC.

CANCERS (2022)

Article Biochemistry & Molecular Biology

Whole-Transcriptome Profiling on Small FFPE Samples: Which Sequencing Kit Should Be Used?

Marc Hilmi, Lucile Armenoult, Mira Ayadi, Remy Nicolle

Summary: RNA sequencing (RNA-Seq) is a powerful tool with significant clinical potential, especially in oncology. This study compared five FFPE-compatible kits for RNA-Seq and found that the Smarter Pico V3 ribodepletion approach was the most reliable and reproducible technique, with comparable performance to Nanostring and Truseq. In addition, the 3' Lexogen kit showed an interesting quality-price ratio for samples with limited quantities.

CURRENT ISSUES IN MOLECULAR BIOLOGY (2022)

Article Urology & Nephrology

Metabolic Syndrome, Malnutrition, and its Associations with Cardiovascular and All-cause Mortality in Hemodialysis Patients: Follow-Up for Three Years

Zohra El Ati, Hanene Machfar, Hamza Boussafa, Nidhal Ati, Olfa Ben Omrane Sioud, Baha Zantour, Hassen Bouzidi, Mohamed Elati

SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION (2020)

No Data Available